
Merlintrader Trading Pub
Biotech catalyst, news and analysis PDUFA tracker

Merlintrader Trading Pub
Biotech catalyst, news and analysis PDUFA tracker
AI transparency: articles and reports are produced with the help of artificial intelligence and checked through a process that does not constitute specialist validation. They may contain errors: verify relevant information with independent sources. Read the full disclaimer.
Oct 16, 2026, 4:55 PM ET
NioCorp reported net income attributable to NioCorp of $3.7 million, or $0.03 per share (basic), for the three-month period ended September 30, 2026, versus a net loss of $42.7 million in the prior-year period.
Nasdaq: $NBCritical minerals · Elk Creek
NB Stock Hub: NioCorp News, Elk Creek Financing and Traxys Sales Terms
NioCorp is advancing Elk Creek with an updated study, portal construction and a new Traxys agreement. The September-quarter Form 10-Q, filed November 5, reports $405.1 million of cash, equivalents and restricted cash at September 30, while projected upfront capital is approximately $1.85 billion. EXIM retains an approximate 65% debt-financing target, subject to its continuing review. NioCorp now plans $85–95 million of cash outflows over the next twelve months, excluding the capital needed to build Elk Creek.
Full research report · PDF
NioCorp Developments Ltd. research · November 1, 2026
19 pages covering the business, financial position, catalysts, risks, scenarios and sources. A dated edition for personal use; redistribution prohibited.
Next financing milestone
No date announced · EXIM due diligence and internal review
The EXIM financing remains subject to due diligence, internal review and approval, final terms and definitive documentation; apart from option and warrant exercises and reimbursements under its Department of War agreement, NioCorp reports no further funding commitments. The September-quarter Form 10-Q was filed on November 5, 2026, ahead of the November 16 target. Form 10-Q
NB stock at a glance
Indicative equity value
424.8
USD million · 2026-11-06 · Calculated $2.90 × 146,472,789 shares outstanding on November 5; dated basic share count, not a fully diluted valuation.
SourceCash, equivalents and restricted cash
405.1
USD million · 2026-09-30 · Form 10-Q: $403.4 million of cash and equivalents plus $1.7 million of restricted cash; unaudited.
SourceQuarterly operating cash flow
-6.2
USD million · 2026-07-01/2026-09-30 · Form 10-Q; the October 16 preliminary figure was −6.1.
SourceQuarterly investing cash flow
-5.6
USD million · 2026-07-01/2026-09-30 · Form 10-Q; capitalized spending, principally the mine portal (preliminary figure −5.9).
SourceProjected upfront project capital
1.85
USD billion · 2026-06-30 · 2026 study estimate, including $233 million contingency; not spending already completed.
SourceEXIM indicated debt-financing target
65.00
percent of upfront capital, approximate · 2026-10-14 · Target retained in the support letter; review continues and financing is not finally authorized or committed.
SourceWhere NioCorp Developments Ltd. stands now
Elk Creek has a more defined technical and commercial framework, but the full construction package remains to be financed and executed. The 2026 study is classified as feasibility under Canadian NI 43-101 and pre-feasibility under U.S. S-K 1300, with additional surface-plant engineering and procurement identified.
The October Traxys agreement separates take-or-pay ferroniobium volume from exclusive marketing rights, without a purchase obligation, for other products. Quarterly net income reported in the Form 10-Q largely reflected noncash financial-instrument gains; operating cash flow remained negative. These distinctions matter when connecting the study to cash available for shareholders.
The main risk is that construction funding, costs, schedule or specialty-product realizations fall short of the study assumptions. Current cash supports development, while a larger financing package, customer acceptance and the economics retained after funding and other claims will determine the common-share outcome.
The constructive case
Engineering, procurement and financing establish an executable construction plan, while qualified customers support the product basket and funding leaves a worthwhile residual equity claim.
The cautious case
Capital or schedule requirements rise, specialty-product realizations disappoint or financing terms transfer much of the projected value away from current common holders.
Read also: Ramaco $METC $AREC $NB $UUUU: Rare Earth Economics →
Latest NioCorp Developments Ltd. news
Oct 16, 2026
Preliminary September-quarter financial update
Cash was preliminarily $405.1 million. Net income of $3.7 million largely reflected noncash instrument gains; operating cash outflow was $6.1 million. Quarterly filing intended on or before November 16.
Oct 15, 2026
EXIM support reiterated with financing review ongoing
The support letter retained an approximate 65% upfront-capital debt target, subject to due diligence and subsequent internal review. It was not final loan approval.
Oct 13, 2026
New Traxys commercial agreement signed
Specified ferroniobium volume has take-or-pay terms. Other products are covered by an exclusive marketing right without a purchase obligation, with commissions and costs affecting realization.
Sep 25, 2026
Annual report and S-K 1300 technical report filed
The annual report gives the updated project economics, capital estimates and ownership structure. The study is a pre-feasibility study under U.S. S-K 1300, alongside its Canadian feasibility classification.
Aug 10, 2026
Updated Elk Creek technical and economic study announced
The modeled project has a forty-year mine life and eight planned product categories. Pre-tax NPV at 8% is approximately $4.1 billion, subject to the study assumptions and funding.
Aug 4, 2026
Non-binding Lockheed Martin memorandum
The memorandum concerns possible purchases of up to fifteen tonnes a year of scandium oxide or corresponding alloy forms over ten years. It is not a definitive purchase commitment.
NB stock catalysts
- 2026-11-05 · September-quarter Form 10-Q filedCompleted, ahead of the November 16 target: $405.1 million of cash, equivalents and restricted cash at September 30; net income attributable to NioCorp $4.2 million
- No firm approval date announced · EXIM due diligence and further internal reviewongoing review; no final loan authorization or financial close established
- Development work before greater cost definition and full execution · Additional surface-plant engineering and procurementrequired work identified in the U.S. technical-study classification
- 2027-12-31 · Traxys financing-related termination conditioncontractual condition, not a company promise of funding; specified extension may apply
- Sixty months after October 13, 2026 execution, subject to stated qualifications · Commercial-production timing condition under Traxys agreementcontractual termination provision with notice and force-majeure terms; not a forecast production date
What the October Traxys terms establish
| Product group | Commercial terms in the filing |
|---|---|
| Ferroniobium | Take-or-pay purchase of 50% of annual output or, at Traxys’ election, 3,700 metric tonnes a year, subject to exclusions. |
| Other products | Exclusive right, without an obligation, to market and sell; commissions and specified costs reduce realization. |
| Duration and development | Fifteen years from the defined commercial-production date, with financing and production timing conditions. |
Financial resources and construction are different scales
| Measure | Amount and status |
|---|---|
| September cash | $405.1 million of cash, equivalents and restricted cash at September 30, 2026 (Form 10-Q, unaudited). |
| Quarterly operating cash flow | Negative $6.2 million, July–September 2026. |
| Planned cash outflows | $85–95 million over the next twelve months, excluding Elk Creek construction capital (Form 10-Q). |
| Projected upfront capital | $1.849 billion, including $233 million contingency, in the 2026 study. |
| EXIM debt target | Approximately 65% of upfront capital, with review continuing and no final commitment established. |
September-quarter Form 10-Q · Study and capital assumptions · EXIM status
Merlintrader Health Score · $NB
2.80out of 5
Assessed November 6, 2026, after the September-quarter Form 10-Q; scores unchanged. Weighted calculation: 3.0×30% + 3.0×30% + 2.0×20% + 3.5×10% + 2.5×10% = 2.80. An editorial assessment of financial and operating resilience over twelve to eighteen months; no price target or recommendation is implied.
Red flags
- EXIM support and an indicated financing target are not final loan authorization or disbursement.
- Traxys has no obligation to purchase the products covered only by its exclusive marketing right.
- Scandium and rare earths contribute materially to projected lifetime revenue.
- Planned cash outflows for the next twelve months rose to $85–95 million in the September-quarter 10-Q, from $65–75 million in the annual report.
- Fiscal 2026 fundraising increased cash and the common-share base substantially.
- Surface-plant engineering and procurement remain important to cost definition and the U.S. study classification.
- Subsidiary interests, warrants, exchanges and future financing affect the value attributable to current common shares.
NB Stock FAQ: NioCorp Developments Ltd. Questions Answered
What is the next NB stock catalyst?
NioCorp filed its September-quarter Form 10-Q on November 5, 2026, ahead of its November 16 target. As of November 6, the next milestone without a fixed date is project financing: EXIM’s October letter supports further review of Elk Creek financing, while due diligence, internal approval, final terms and documentation remain pending. September-quarter Form 10-Q. EXIM letter of support.
Is NioCorp profitable?
NioCorp’s Form 10-Q reports net income of US$3.8 million for the quarter ended September 30, 2026, and US$4.2 million attributable to the company (US$0.03 per basic share), against the preliminary US$3.7 million released on October 16. The result largely reflects about US$8.5 million of noncash gains on earnout shares and warrants classified as liabilities. Operating cash outflow was US$6.2 million in the quarter, so the accounting profit did not represent positive operating cash flow. September-quarter Form 10-Q. Preliminary September-quarter results.
How much cash does NioCorp have?
NioCorp held US$403.4 million of cash and cash equivalents plus US$1.7 million of restricted cash at September 30, 2026, according to its Form 10-Q, after US$6.2 million of operating cash outflow during that quarter. The 10-Q puts planned cash outflows at about US$85–95 million over the next twelve months, up from US$65–75 million in the fiscal-year filing issued in September, and expects September cash, together with any option and warrant exercises and Department of War reimbursements, to cover them. Developing and constructing Elk Creek requires additional project financing beyond that spending plan. September cash and planned outflows. Liquidity and planned expenditures.
Is NB stock at risk of dilution?
Yes: NioCorp’s Form 10-Q reports 146,472,789 common shares outstanding on November 5, 2026, against 145,849,630 on September 25, together with options, warrants and exchangeable interests that can increase the share count. Further equity financing could also dilute existing holders. A potential Traxys equity investment of up to US$30 million was still under discussion in the October 13 announcement; it was separate from the commercial sales agreement, and the 10-Q reports no funding commitments beyond option and warrant exercises and Department of War reimbursements. November 5 share count and funding commitments. Share capital and financing risks. Traxys commercial agreement and potential investment.
When does NioCorp report earnings?
NioCorp released preliminary unaudited September-quarter results on October 16, 2026 and filed its Form 10-Q on November 5, 2026, without an earnings call. The final figures confirmed $405.1 million of cash, equivalents and restricted cash and showed net income attributable to the company of $4.2 million, against the preliminary $3.7 million. As of November 6, the company had not announced the date of its next quarterly report. September-quarter Form 10-Q. Preliminary results.
What does NioCorp do?
As of November 6, 2026, NioCorp is developing Nebraska’s Elk Creek project for niobium, scandium, titanium and rare-earth products, while already producing aluminum-scandium master alloy in the United States using purchased scandium. Elk Creek remains a development project. Its 2026 technical study is classified as feasibility under Canadian NI 43-101 standards and pre-feasibility under U.S. S-K 1300; further surface-plant engineering and procurement work is needed for the U.S. feasibility classification. Business and technical-study classifications. Existing alloy production and planned mine output.
Has EXIM approved a loan for NioCorp’s Elk Creek mine?
No final EXIM loan authorization was announced in NioCorp’s October 15, 2026 update: the letter reiterated a target to finance approximately 65% of Elk Creek’s upfront capital costs. Due diligence and internal review remain necessary. EXIM’s own announcement describes a letter of support and prospective Board authorization, rather than money already committed and disbursed. Financing target and review conditions. EXIM announcement.
Does NioCorp have buyers for Elk Creek’s planned production?
NioCorp’s October 13, 2026 Traxys agreement provides take-or-pay purchases for 50% of planned ferroniobium production over fifteen years; other products have exclusive purchase and marketing rights without purchase obligations. The remaining ferroniobium has a pre-existing ThyssenKrupp agreement for ten years. Deliveries depend on project financing, construction and production. Separately, the August 4 Lockheed Martin memorandum for potential scandium purchases is nonbinding and requires a definitive agreement. Traxys and ThyssenKrupp sales terms. Nonbinding Lockheed Martin memorandum.
Primary sources and market references
- November 5, 2026 · Form 10-Q for the quarter ended September 30, 2026: cash, planned outflows, EXIM status and 146,472,789 shares
- October financial update filed with the SEC
- EXIM support announcement
- Company explanation and signed letter
- October agreement summary
- Corporate and subsidiary description
- August downstream update
- S-K 1300 technical report
- Signed October letter
- Nasdaq historical prices
Disclaimer. Published by Merlintrader for educational and informational purposes only. This content does not constitute investment advice or a recommendation to buy, sell or hold securities. Verify figures against the dated primary disclosures. Investors can lose part or all of their capital.
Mineral-development companies face geological, processing, construction, permitting, environmental, customer, commodity-price, financing and dilution risks. Technical-study economics depend on assumptions and do not determine equity value. Government support can remain conditional, marketing agreements may lack purchase obligations, and project interests and future capital can change the value retained by common shareholders.
Merlintrader may hold positions in securities mentioned. Some links on this page are affiliate or referral links, including those to Finviz, which may generate a commission at no cost to the reader. Full legal information: disclaimer and terms of use and privacy.



